Blood Collection Market

Market Overview

The global blood collection market size was valued at USD 11.07 billion in 2022. It is estimated to reach USD 19.67 billion by 2031, growing at a CAGR of 6.6% during the forecast period (2023–2031). The global increase in accidents and trauma cases is a significant catalyst for the growth of the blood collection industry.

Blood collection is the voluntary removal of blood from the body for laboratory analysis. The volume of blood extracted or expelled from a donor should not be proportional to his weight. Blood is collected manually or through the use of machine-controlled technology. Blood analysis is used to diagnose both chronic and acute illnesses. Hospitals typically collect it to identify metabolic, respiratory, and mixed-acid disorders. Arterial, venipuncture, and fingerstick sampling are common blood collection techniques.

Blood collection is critical in understanding, preventing, and treating disease in hospitals and blood bank centers. Apheresis separates the blood's various components after it has been extracted using automated or manual methods. Depending on the need, blood samples can also be collected from the arm, ear, hand, and other body areas. The integrity of blood and blood samples must be maintained within the stringent temperature and pressure parameters for accurate blood analysis and prognosis.

Market Dynamics

Global Blood Collection Market Drivers

Rising Number of Accidents and Trauma Cases

The rise in accidents and trauma cases globally is a major factor driving the blood collection market. Blood collection products are required to treat patients suffering from injuries because of trauma or accidents. According to the WHO, an estimated 1.25 million individuals die from road accidents globally. Moreover, an increase in road accidents leads to an additional demand for blood and blood components.

Additionally, trauma injuries result from physical injuries that occur suddenly and require immediate medical attention. According to the National Trauma Institute, trauma injuries contributed to 30% of lives lost globally. Likewise, according to the CDC, every year, 2.5 million individuals visit emergency departments to treat traumatic brain injury in the U.S., which is expected to rise soon. These facts indicate the rising incidence of trauma injuries requiring blood collection products for effective treatment.

Increasing Number of Surgical Procedures

A global increase in the frequency of severe chronic diseases and accident cases has been linked to an increase in the number of surgical procedures reported. According to Stanford Health Care, 48 million surgical inpatient procedures were performed in the U.S. Nervous system surgeries constituted 1.2 million surgeries, indicating a steady rise in neurological diseases in the U.S. Moreover, as per the American Society for Aesthetic Plastic Surgery, Americans spent more than USD 15 million on aesthetic surgical procedures in 2017. Thus, the need for blood collection products has been fueling the market expansion, thanks to the increasing number of surgical procedures.

Global Blood Collection Market Restraint

Risks Associated with Blood Transfusions

Blood transfusion is a common technique performed only after elaborate compatibility testing. Most often, there are no risks associated with blood transfusion. However, complications may arise even after several months or weeks of transfusion. These complications include immune-related or nonimmune reactions.

Fever, acute immune hemolytic reactions, lung injury, blood-borne infections, delayed hemolytic reaction, iron overload, and graft vs host disease are some of the complications that might arise from a blood transfusion. These complications occur only when errors are made in the recipient and donor blood matching despite many efforts taken by clinicians to prevent them. These risks can prove to be fatal if not treated immediately and thus can limit the market growth.

Global Blood Collection Market Opportunities

Growing Availability of PoC Diagnostics

Several smartphone-based devices and associated tools have arisen as point-of-care diagnostics or testing devices of the next generation, driving market expansion. For instance, a smartphone application paired with an autonomous microfluidic capillary chip is used to swiftly test cardiac troponin I in myocardial infarction. This platform is simple to use in environments with limited resources and provides test results within 12 minutes.

Capillary blood collection devices have emerged as the go-to testing mode in remote and ambulatory health settings when combined with PoC diagnostics. Anemia is one of the most common nutritional deficiencies among adult women. This procedure is preferred over venous and arterial blood procedures as they require few blood samples. Owing to their advantage, they are used for various hematology tests in pediatric and adult populations. Therefore, with the rising adoption of rapid PoC diagnostics, usage of capillary blood collection devices is estimated to increase soon, thereby creating opportunities for market growth.

Regional Analysis

North America Dominates the Global Market

Based on region, the global blood collection market is bifurcated into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

North America is the most significant global blood collection market shareholder and is anticipated to exhibit a CAGR of 5.7% during the forecast period. North America held the largest share in the blood collection market owing to the increase in the number of surgical procedures, the rising number of accidents and trauma cases, and the increase in several non-communicable and infectious diseases in this region. The rise in the number of initiatives undertaken by various public and private organizations to enhance plasma donations in the U.S. is expected to fuel market growth. For instance, in April 2020, the US Hindu organization set up a program for COVID-19 survivors to donate blood plasma. This donation aided in plasma therapy for treating COVID-19 and ill patients with respiratory failure.

Furthermore, Sewa International developed an online register for the convalescent plasma therapy program to facilitate communication between participants in the COVID-19 treatment and donors. Moreover, the U.S. FDA approved the plasma therapy for coronavirus treatment. Therefore, increased plasma donations during the COVID-19 treatment enhanced the adoption of blood collection products during the forecast period.

Europe is estimated to exhibit a CAGR of 6.1% over the forecast period. This is owing to the local presence of various key players, an increase in the adoption of novel products, a rise in the number of blood transfusions and donation campaigns, and growth in strategic initiatives undertaken by governments, public and private organizations, as well as market players. In 2018, the European Commission reported that approximately 15 million regional individuals give blood annually. Moreover, there are approximately 1,400 blood establishments, and around 25 million blood units are transfused annually in the region. Therefore, an increase in blood transfusions is expected to expedite market growth during the forecast period.

In Asia-Pacific, most countries are economically developing with increasing disposable incomes. Several multinational businesses are investing heavily in this region. The region's market expansion can be aided by countries like Japan, which have highly advanced healthcare and medical research systems. In 2016, 5,995,000 people in India lost their lives to non-communicable diseases; this figure is expected to rise, as per the World Health Organization. Men and women in the area died most often from cardiovascular disease and chronic lung disease.

Moreover, the increase in the incidence of road accidents in India is boosting the demand for blood collection products. According to the Government of India, road accidents resulted in 146,133 deaths in 2015, which is expected to rise significantly soon. The presence of various CROs and an increase in healthcare investments are expected to drive the market in this region.

Brazil and Mexico dominate Latin America's blood collection market. The demand for capillary blood collection devices in Latin America is expected to grow at a lucrative CAGR throughout the forecast period, owing to the presence of emerging economies. According to the Population Reference Bureau, major Non-communicable Diseases (NCD) are expected to contribute to approximately 81% of deaths in 2017, which include cardiovascular diseases, cancer, and chronic respiratory diseases. Obesity and smoking are the key factors contributing to the increasing prevalence of these diseases in this region. Premature deaths due to NCDs, particularly among men, are high. As a consequence, a huge number of surgical procedures that make use of capillary blood collection devices are being performed, thereby fueling market growth.

Segmental Analysis

The global blood collection market is segmented by collection site, application, and end-user.

Based on the collection site, the global blood collection market is segmented into venous and capillary blood collections. 

The venous segment dominates the global market and is expected to grow at a CAGR of 6.5% over the forecast period. Phlebotomy is a common technique that consists of temporarily inserting a needle in the vein to provide venous access for blood sampling. Veins consist of a three-layered wall of endothelium and surrounded by thin layers of muscle fibers covered by a layer of connective tissue. Identifying an optimal site for venous access involves both tactile and visual evaluation. The doctor checks possible sites by palpating them after placing a venous tourniquet.

Moreover, some venous blood collection devices are holders, needles, and collection tubes. Greater emphasis is being made on the prevention of injuries, reduction in exposure to blood-borne pathogens, and advancing safety features, which are some of the factors anticipated to fuel segment growth.

Capillary blood collection allows an individual to draw blood in a precise and small amount. This procedure makes it easy to collect samples, which can lead to various innovations in consumer health and wellness. This procedure for microsampling quantitative amounts of blood is accumulating immense traction in the healthcare sector. By drawing small and precise volumes of blood, microsampling provides advantages in precision medicine and can offer more specific testing. Lancets, micro-container tubes, micro-hematocrit tubes, and warming devices are the products used for capillary blood collection.

Based on application, the global blood collection market is divided into diagnostics and treatment segments. 

The diagnostics segment is the most significant contributor to the market and is estimated to exhibit a CAGR of 7.01% over the forecast period. Most blood collection products are utilized in diagnostics, as blood samples are needed to diagnose the source of infections caused by pathogenic microorganisms or to identify abnormalities in blood components. The presence of foreign substances in a patient's blood can be assessed by pathological testing and then accordingly treated. Dried blood spot tests are bio-sampling tests that facilitate easy and rapid diagnosis of various diseases.

Moreover, dried blood samples are used in analytical testing and diagnosis to detect HIV, HBV, HCV, and other infections. These tests have been conventionally used for newborn screening to detect congenital metabolic disorders. Capillary blood sampling is frequently used in these tests, as they require low blood samples, making them ideal for pediatric use. Therefore, these tests are anticipated to witness lucrative growth during the forecast period.

Blood collection products treat various disorders, including chronic kidney disorders, various types of cancers, autoimmune disorders, and neurological conditions. A patient may require a transfusion of blood or blood components—such as platelets, plasma, and granulocytes—during the treatment of a severe infection or after blood loss during surgery or post-injury. Blood and blood components are in high demand because of the rising number of surgeries and accidents. In addition, the demand for blood during cancer treatment has increased.

Based on end-users, the global blood collection market is divided into hospitals, diagnostic centers, blood banks, emergency departments, and others. 

The hospital segment is the largest revenue contributor to the market and is expected to exhibit a CAGR of 6.1% over the forecast period. Hospitals have been the largest revenue-generating segment in the blood collection market, owing to the high number of cases and diagnostic tests being conducted. Hospital blood transfusion needs have skyrocketed due to an increase in surgical operations like angioplasty and kidney and liver transplants, as well as an increase in the frequency of injuries. Moreover, there is a significant demand for the diagnosis of several diseases, including cancer, heart or lung diseases, sickle cell anemia, and blood disorders such as thalassemia and hemophilia. There has been a significant increase in the prevalence of infectious diseases like malaria, dengue, hepatitis, and pneumonia, which require capillary blood collection devices for early detection and diagnosis.

Blood donation centers operate as individual centers; however, some hospitals and clinics may have collection centers. After collection, the blood is processed, tested for disease-causing factors, and separated into components depending on the need. Leading companies are predicted to boost their research and development spending to fuel the creation and release of new products and devices in the market, propelling the segment to greater heights. Growth in surgeries and trauma-related incidents are driving the demand for blood and blood components. Therefore, screening and blood testing are vital before blood transfusions. These are most often performed with capillary blood, thereby propelling segment growth.

Recent Developments

• March 2023-Dutch medical robotics company Vitestro raised EUR 12 million in Series A funding to introduce what it claims is the world's first autonomous blood-drawing device in the European market. Existing investors and new private investors contributed to the funding round led by US-based Sonder Capital.
• April 2023- YourBio's remote blood collection device received 510(k) certification from the United States FDA. The Touch Activated Phlebotomy (TAP) Micro Select is utilized for diagnostic microcapillary blood testing.